Giuseppe Andres
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giuseppe Andres.
American Journal of Pathology | 1999
Shoichi Maruyama; E. Cantu; Cesare DeMartino; Catherine Wang; Jonathan M. Chen; Futwan Al-Mohanna; Shaheen M. Nakeeb; Benvenuto Pernis; Uri Galili; Gabriel C. Godman; David M. Stern; Giuseppe Andres
As barriers to xenotransplantation are surmounted, such as suppression of hyperacute rejection allowing improved graft survival, it becomes important to define longer-term host-xenograft interactions. To this end we have prepared in baboons high titer anti-α-Galactosyl (αGal) and anti-porcine aortic endothelial cell antibodies, similar to human natural xenoantibodies and reactive with epitopes of thyroglobulin, laminin, and heparan sulfate proteoglycans. When injected into pigs with a protocol similar to that used in the rat to show the nephritogenic potential of heterologous anti-laminin and anti-heparan sulfate proteoglycan antibodies, baboon immunoglobulins bound first to renal vascular endothelium, and later to interstitial cells, especially fibroblasts and macrophages, and to antigens in basement membranes and extracellular matrix, where they colocalized with laminin- and heparan sulfate proteoglycan-antibodies, and with bound Griffonia simplicifolia B4. A similar binding was observed in other organs. The pigs did not develop an acute complement-dependent inflammation, but rather chronic lesions of the basement membranes and the extracellular matrix. Incubation of renal fibroblasts with baboon anti-α-Galactosyl antibodies resulted in increased synthesis of transforming growth factor-β and collagen, suggesting a possible basis for the fibrotic response. The results demonstrate that in this experimental model a consequence of αGal antibody interaction with porcine tissues, is immunoreactivity with αGal on matrix molecules and interstitial cells, priming mechanisms leading to fibrosis resembling that in chronic allograft rejection. The possibility that similar lesions may develop in long-surviving pig xenografts is discussed.
Transplantation | 2000
Luigi Biancone; Vincenzo Cantaluppi; Giuseppe Paolo Segoloni; Mariarosaria Boccellino; Lorenzo Del Sorbo; Pier Giulio Conaldi; Larry W. Tjoelker; Shoici Maruyama; E. Cantu; David M. Stern; Giuseppe Andres; Giovanni Camussi
BACKGROUNDnPlatelet-activating factor (PAF) is a phospholipid mediator of inflammation which has been implicated in rejection. The interaction of anti-alpha-galactosyl natural antibodies (anti-alpha gal Abs) with endothelial cells is the initial step for the development of xenograft rejection. In our study, we stimulated porcine aortic endothelial cells (PAEC) with anti-alpha gal IgG to investigate the synthesis of PAF from PAEC and its biological consequences.nnnMETHODS AND RESULTSnPAF was extracted and chromatographically purified from cultured PAEC stimulated with baboon anti-alpha gal Abs. The Abs induced a dose-dependent synthesis of PAF peaking after 30 min of incubation, and decreasing thereafter. Concomitant cell shape change, motility, and cytoskeleton redistribution were observed. These events were prevented by addition of a panel of PAF-receptor antagonists. An SV40 T-large antigen-immortalized PAEC line was engineered to express PAF acetyl-hydrolase (PAF-AH) cDNA, the major PAF-inactivating enzyme. These transfected cells exposed to anti-alpha gal Abs showed reduced cell contraction and motility compared with empty vector-transfected cells. Moreover, in PAEC stimulated with anti-alpha gal Abs, the synthesis of PAF promoted the adhesion of a monocytic cell line as shown by the inhibitory effect of PAF-receptor antagonists and of PAF-AH expression. Finally, studies on cell monolayer demonstrated an enhanced permeability 48 hr after exposure to anti-alpha gal Abs, and this increase was prevented by PAF-inactivation and by PAF-receptor blockade.nnnCONCLUSIONSnThese results demonstrate that on stimulation with anti-alpha gal Abs, PAEC synthetize PAF which can contribute to several vascular events involved in xenograft rejection.
International Archives of Allergy and Immunology | 1993
Giovanni Camussi; Gregory Biesecker; Peter R.B. Caldwell; Luigi Biancone; Giuseppe Andres; Jan R. Brentjens
The potential pathogenic role of the membrane attack complex (MAC) of the complement system was investigated in two models of lung injury mediated by antibodies to angiotensin-converting enzyme (ACE), an endothelial cell enzyme. In the first model, acute and fatal lung edema was induced in rabbits by intravenous administration of divalent anti-ACE antibodies. These animals died acutely. C6-deficient rabbits tolerated anti-ACE antibodies without apparent ill effects. On the other hand, C6-deficient rabbits reconstituted with C6 and then receiving anti-ACE antibodies developed acute pulmonary edema and died. These results indicate that the MAC is required for the pathogenesis of this lung injury. In the second model, intravenous administration of monovalent anti-ACE Fab fragments over 4 consecutive days induced fatal interstitial pneumonitis in normal rabbits. For C6-deficient rabbits there was a reduced inflammatory response, and no animals died, implicating a mediator function for the MAC in this model as well. These results demonstrate that MAC is an important mediator of acute pulmonary edema induced by divalent antibodies to an endothelial antigen. Moreover, the complement system was also, to some extent, involved in the recruitment of inflammatory cells leading to the development of interstitial pneumonitis in the experimental lung injury induced by monovalent anti-ACE Fab fragments that per se do not activate complement.
International Archives of Allergy and Immunology | 1972
K. Kano; Giuseppe Andres; Konrad C. Hsu; F. Milgrom
The association of HL-A antigens with human species-specific antigens has been investigated by means of mixed agglutination tests and immuno-electron microscopy. Cultures of an established human cell
Journal of Immunology | 1982
Giovanni Camussi; M. Rotunno; G. Segoloni; Jan R. Brentjens; Giuseppe Andres
Transplantation | 1990
Zhow Xj; Niesen N; Pawlowski I; Biesecker G; Giuseppe Andres; Jan R. Brentjens; Milgram F
Journal of Immunology | 1987
Giovanni Camussi; G Salvidio; G Biesecker; Jan R. Brentjens; Giuseppe Andres
American Journal of Pathology | 1961
Jan L. E. Ericsson; Giuseppe Andres
American Journal of Pathology | 1995
Y. Yuzawa; J. Brett; A. Fukatsu; S. Matsuo; P. R. B. Caldwell; N. Niesen; F. Milgrom; G. Godman; David M. Stern; Giuseppe Andres
Journal of Immunology | 1993
Y. Yuzawa; Jan R. Brentjens; J. Brett; P. R. B. Caldwell; C. Esposito; A. Fukatsu; G. Godman; David M. Stern; Giuseppe Andres